# Abbott Laboratories (ABT) — Q1-2022 Earnings Results

**Report date:** 2022-04-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q1-2022

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 2.22%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.73 | N/A | +17.77% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported a strong earnings per share, exceeding expectations by nearly 18%. The stock reacted positively, rising by 2.22%. However, without revenue data or management commentary, it’s difficult to assess the overall performance and future outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q1-2022_